Sequana Medical NV (EBR:SEQUA)
Belgium
· Delayed Price · Currency is EUR 1.030
-0.054 (-4.98%)
Apr 24, 2025, 5:35 PM CET
Sequana Medical NV Revenue
Sequana Medical NV had revenue of 105.50K EUR in the half year ending June 30, 2024, a decrease of -77.28%. This brings the company's revenue in the last twelve months to 433.50K, down -48.54% year-over-year. In the year 2023, Sequana Medical NV had annual revenue of 712.17K, down -22.82%.
Revenue (ttm)
433.50K
Revenue Growth
-48.54%
P/S Ratio
516.14
Revenue / Employee
2.20K
Employees
62
Market Cap
54.45M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 712.17K | -210.51K | -22.82% |
| Dec 31, 2022 | 922.69K | 552.19K | 149.04% |
| Dec 31, 2021 | 370.50K | -592.78K | -61.54% |
| Dec 31, 2020 | 963.28K | -7.36K | -0.76% |
| Dec 31, 2019 | 970.64K | -58.54K | -5.69% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| argenx SE | 2.17B |
| UCB SA | 6.15B |
| Financière de Tubize | 13.26K |
| Fagron NV | 871.96M |
| Ion Beam Applications | 465.75M |
| Nyxoah | 4.52M |
| Hyloris Pharmaceuticals | 10.04M |
| Onward Medical | 1.70M |
Sequana Medical NV News
- 5 weeks ago - Sequana Medical NV GAAP EPS of -€1.22, revenue of €0.106M - Seeking Alpha